Skip to search formSkip to main contentSkip to account menu

CREKA-Tris(Gd-DOTA)3

Known as: CREKA-Tris-Gd(DOTA)3 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Coordination ComplexesOligopeptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A Bioinspired Nanoprobe with Multilevel Responsive T1‐Weighted MR Signal‐Amplification Illuminates Ultrasmall Metastases
Metastasis remains the major cause of death in cancer patients. Thus, there is a need to sensitively detect tumor metastasis… 
Highly Cited
2015
Highly Cited
2015
MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent
Metastasis is the primary cause of death in breast cancer patients. Early detection of high-risk breast cancer, including… 
2015
2015
Molecular Imaging of Tumors Using a Quantitative T1 Mapping Technique via Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) of glioblastoma multiforme (GBM) with molecular imaging agents would allow for the specific… 
Highly Cited
2013
Highly Cited
2013
Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.
2013
2013
Molecular Magnetic Resonance Imaging of Tumors with a PTPµ Targeted Contrast Agent.
Molecular magnetic resonance imaging (MRI) of tumors improves the specificity of MRI by using targeted probes conjugated to… 
2012
2012
Synthesis and evaluation of CREKA-Tris(Gd-DOTA)3 for MR molecular imaging of breast cancer
Purpose: MRI is a powerful medical imaging modality to display anatomical structures of body, especially useful for the detection… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)